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Breast brachytherapy (BT) with rigid needles was the first way
to boost the bed tumor avoiding skin. Several long-term stud-
ies have shown that HDR-BT can be used in 1–2 fractions in
one day, on an outpatient basis, which is far more comfort-
able than LDR-BT. The needles, fixed with templates, allow
an excellent dose-homogeneity with the optimization of HDR.
Clips are useful to delineate the tumor bed, performing a CT
for dosimetry, but it is not easy to draw it when an open cavity
has disappeared. Most studies define the tumor bed by clinical
assessment, according to the mammography, patient and sur-
geon’s initial description, and palpation. The target is defined
as the tumor bed plus a margin of 1–2 cm, avoiding 1 cm from
skin and from the entrance of the needles. If the tumor loca-
tion is not clearly defined, a larger implant is used to avoid a
geographical miss. The shape of the breast can be modified
if needed because the templates keep the needles in place.
Dosimetry calculations are theoretical, making a reconstruc-
tion of catheters, because the distance between needles is
constant. The total procedure is easy and quick, takes around
2–3 h, and is called “Fast-boost”.
Historically, like rigid needles, breast brachytherapy with
plastic tubes is performed in the operating room. This was
either done at the time of lumpectomy or as a separate
procedure following lumpectomy with pathologic evaluation
completed and information available. Although there are dif-
ferent techniques of catheter placement, general guidelines of
catheter placement are consistent. Stainless steel guide nee-
dles are introduced into the breast tissue at the appropriate
locations. Once its placement is complete they are replaced
with button-ended flexible after loading plastic tubes and
secured with proper fixation buttons. Implant construction is
governed by basic breast brachytherapy principles with the
goal of optimizing target coverage and dose homogeneity and
it is easily when it is done in intra – operative time because
we can see tumor bed and discuss with surgeon tumor local-
ization. For both, intra or postoperative implants, dosimetric
planning can be managed with a two or three dimensional
planning process utilizing dummy source strands in each
catheter with subsequent orthogonal films or more recently
using a CT. The main advantages of plastic tube are that
the implant is probably better tolerated by the patient, but
is more difficult to contain the optimal geometry (paral-
lelism, inter catheter spacing and distance to the overlying
skin).
The plesiobrachytherapy consist of an applicator contain-
ing an array of radioactive sources usually designed to deliver
a uniform doses distribution to skin. It can be used only for
very superficial lesions (up to 5 mm target depth). The applica-
tor must be adapted to the topography of the tumor. Irregular
and curved areas can be treated. Fixation and immobiliza-
tion are crucial. Indication is breast cancer recurrences after
mastectomy (inoperable) in already irradiated areas. The guide
system consisted of plastic tubes inserted at 1.5 cm intervals
into flexible silicone plates that were applied to skin surface
to maintain the actives lines 0.5 cm above the skin surface.
The high dose sleeves surrounding the actives lines were con-
tained within the thickness of the silicone plate. The length
of the sources has to be adapted to the length of the PTV, cal-
culated previously to the application. Computations for the
doses desired are carried out, and optimal placement of the
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sources is determined. It requires more thorough studies to
establish optimum time, dose y fractionation. The patients
were treated with a doses de 5 Gy per fraction, twice a week
for three to four weeks to deliver a total dose 30–40 Gy in six
to eight fractions (HDR). A total dose of 60 Gy was delivered a
reference isodoses located 2–4 mm under skin surface, using
two or three courses (PDR). Total treatment is spread over a
time period and tumor regression as well as radiation reac-
tions can be observed and if required, treatment modification
can easily be made.
